CA-VELODYNE-LIDAR,-INC.
7.1.2020 03:02:12 CET | Business Wire | Press release
Velodyne Lidar, Inc. today announced Anand Gopalan as its new CEO. Gopalan, who previously was Velodyne’s CTO, assumes the position from Velodyne’s legendary founder David Hall. Hall will continue as full-time Chairman of the Board and remain actively involved in directing the company’s technology, product vision and business strategy.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200106006044/en/
Gopalan is a distinguished engineer and technology executive with experience building and leading worldwide engineering organizations. He came to Velodyne in 2016 to form an advanced research and development team. Gopalan leads Velodyne’s customer-focused technology and product development teams to address market needs for lidar solutions designed for high performance, cost optimization and high-volume production.
Over the past three years, Gopalan has worked closely with Hall to develop the company’s technological roadmap and strategic vision. Gopalan is recognized across the industry as a thought leader in business as well as in technology. Recently, Gopalan became more active as a spokesman for the company, expertly explaining the benefits and the workings of lidar to audiences around the world. It is the policy of Velodyne to promote from within the company and Gopalan was a natural choice, having proved himself in 2019.
Gopalan and the Velodyne team look forward to building on the company’s growth trajectory. Due to the breadth and versatility of the Velodyne lidar portfolio, the company continues to make revolutionary contributions to the ever-expanding autonomous industry. Velodyne is a recognized leader in a wide range of markets including automotive, mapping, on-demand mobility, robotics, security, unmanned aerial vehicles (UAV) and more.
Under Gopalan’s leadership alongside Hall, Velodyne brought to market a series of breakthrough lidar products, including the Alpha Prime™, Velarray™, VelaDome™ and a new game-changing lidar sensor, soon to be used for powerful Advanced Driver Assistance Systems (ADAS). Due to its low cost, this sensor will advance automotive safety for the everyday car owner. At CES 2020, Velodyne will unveil the new lidar sensor and Gopalan will discuss his vision for the company at a press conference in the Velodyne booth #7520 on Tuesday, January 7, at 11:00 a.m. PST.
David Hall invented groundbreaking 3D lidar sensor technology in 2005 which set the stage for revolutionizing the automobile industry and was the foundation for Velodyne’s market leadership. The idea of leveraging lidar technology for autonomous driving came to Hall while participating in the DARPA Grand Challenge for autonomous vehicles. Holding more than 30 U.S. patents, Hall is a technology visionary and serial inventor covering a variety of applications, including lidar, audio and marine. The Intellectual Property Owners Education Foundation presented Hall with its 2018 Inventor of the Year Award.
“Anand Gopalan and I have worked side-by-side on Velodyne’s technology roadmap. He is the right executive to lead Velodyne in its next growth phase,” said Hall. “His finger is on the pulse of customer and market needs while possessing the technical brilliance and leadership skills to innovate and deliver. As Chairman, Anand has my full support while I continue to provide vision, strategize and invent.”
“David Hall is more than the founder of Velodyne, he is also the founder of our industry. I am grateful for the trust he has placed in me and excited to lead a company with such a deep history in innovation as Velodyne. We are the forefront of our market, ready to drive the age of autonomy. Velodyne is bringing improved mobility and safety through versatility, responsiveness and agility,” said Gopalan.
Elevating Gopalan to CEO will enhance the leadership team at Velodyne Lidar, running day-to-day business as the company addresses U.S. and global market opportunities. Gopalan and Hall will continue to be supported by a strong bench of Velodyne executive C-staff, including Marta Hall, Chief Marketing Officer (CMO), Rick Tewell, Chief Operating Officer (COO), Mike Jellen, Chief Commercial Officer (CCO), Drew Hamer, Chief Financial Officer (CFO), Barbara Rogan, General Counsel, and Mircea Gradu, Senior Vice President of Product and Quality.
About Velodyne Lidar
Velodyne provides smart, powerful lidar solutions for autonomy and driver assistance. Headquartered in San Jose, Calif., Velodyne is known worldwide for its portfolio of breakthrough lidar sensor technologies. Velodyne’s Founder, David Hall, invented real-time surround view lidar systems in 2005 as part of Velodyne Acoustics. Mr. Hall’s invention revolutionized perception and autonomy for automotive, new mobility, mapping, robotics, and security. Velodyne’s high-performance product line includes a broad range of sensing solutions, including the cost-effective Puck™, the versatile Ultra Puck™, the autonomy-advancing Alpha Prime™, the ADAS-optimized Velarray™ and the groundbreaking software for driver assistance, Vella™.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200106006044/en/
Contact:
Sean Dowdall Landis Communications Inc. for Velodyne Lidar, Inc. (415) 286-7121 velodyne@landispr.com
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alnylam Presents New Data at ESC Congress 2026 Reinforcing Strength in RNAi-Powered TTR Silencing Across ATTR-CM Patient Populations and Treatment Settings30.8.2026 14:23:00 CEST | Press release
–Late-Breaking Prespecified Subgroup Analysis of HELIOS-B Demonstrates that Vutrisiran Provided Consistent Clinical Benefit Across All-Cause Mortality and Recurrent Cardiovascular Events in Patients With or Without Tafamidis Use at Baseline ––Additional Post Hoc Analyses Highlight Positive Impact of Vutrisiran in Addressing the Multisystemic Manifestations of ATTR-CM ––Pooled Analysis Across Four Positive Phase 3 Studies of Vutrisiran and Patisiran Shows Consistent Treatment Effect Across Sexes ––New Subgroup Analysis from KARDIA-3 Phase 2 Study of Zilebesiran Highlights Potential to Provide Enhanced Blood Pressure Control – Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced new data at the European Society of Cardiology (ESC) Congress 2026 demonstrating the strength of RNAi-powered silencing for cardiovascular disease. The findings further reinforce the clinical profile of AMVUTTRA® (vutrisiran) across transthyretin amyloidosis (ATTR)
New Auction Record Set as Falcon Sells for AED 1.5 Million at ADIHEX 202629.8.2026 23:54:00 CEST | Press release
Qarmousha Pure Ultra White falcon sells for AED 1.5 million at the Abu Dhabi International Hunting and Equestrian Exhibition 2026 (ADIHEX) falcon auction Under the patronage of His Highness Sheikh Hamdan bin Zayed Al Nahyan, Ruler’s Representative in Al Dhafra Region and Chairman of the Emirates Falconers’ Club, the fifth auction held as part of the 23rd edition of the Abu Dhabi International Hunting and Equestrian Exhibition (ADIHEX) 2026 attracted remarkable turnout, culminating in the sale of a Qarmousha Pure Ultra White falcon for AED 1.5 million (USD 408,000). The sale marks the highest price achieved at any auction during this year’s edition of the exhibition. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260829032621/en/ Qarmousha Pure Ultra White (Photo: AETOSWire) This forms part of the largest auction programme in the exhibition’s history, held under the theme “A Legacy of Pride,” organised by ADNEC Group, a Modon
Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 00:40:00 CEST | Press release
MIMRYLO, a First-in-Class Medicine with a Unique Mechanism of Action, is Approved for the Treatment of Erythrocytosis in Adults with Polycythemia Vera (PV)MIMRYLO Has Been Shown to Maintain Hematocrit Control, the Primary Treatment Goal in PV, as Well as Reduce Phlebotomy Burden and Improve FatigueApproval Supported by Phase 3 VERIFY Results Showing 76.9% of Patients Achieved Clinical Response During Weeks 20-32 Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the tot
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom